Robert A. Ingram began his career in the pharmaceutical industry as a professional sales representative and rose through a series of roles with increasing responsibility to ultimately become CEO/chair of GlaxoWellcome. He co-led the merger and integration that formed GlaxoSmithKline, the world's second largest pharmaceutical company. Upon reaching the mandatory retirement age of 60, he was asked by the board to serve as vice chair Pharmaceuticals, GSK.
Ingram serves as chair, OSI Pharmaceuticals, Inc. He also serves on the Board of Directors of Allergan Inc., Edwards Lifesciences Corporation, Lowe's Companies, Inc., Nortel Networks, Valeant Pharmaceuticals International and the Wachovia Corporation.
He is vice chair, American Cancer Society Foundation; founder of CEO Roundtable on Cancer; chair of American Foundation for Pharmaceutical Education; and member of the Boards for Business Higher Education Forum, James B. Hunt Jr. Institute for Educational Leadership and Policy, Project HOPE, Research Triangle Foundation of North Carolina and member of National Board for Professional Teaching Standards President's Roundtable.
Ingram graduated from Eastern Illinois University with a BS degree in Business Administration.